Twinrix Paediatric Injection is a combination of two medicines: Inactivated Hepatitis A Vaccine (Adsorbed) and Hepatitis B Vaccine (rDNA) which prevent Hepatitis A and Hepatitis B. They help develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Twinrix Paediatric Injection may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Twinrix Paediatric Injection is safe to use during lactation.
Human studies have shown that either the drug does not pass into the breastmilk in significant amount or is not expected to cause toxicity to the baby.
It is not known whether Twinrix Paediatric Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Twinrix Paediatric Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Twinrix Paediatric Injection may not be needed in these patients. Please consult your doctor.
Twinrix Paediatric Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Twinrix Paediatric Injection may not be needed in these patients. Please consult your doctor.
What are you using Twinrix Paediatric Injection for?
Hepatitis A prophylaxis
Survey Participants: 1
“The following are the results of on-going survey on 1mg.com for Twinrix Paediatric Injection. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 10th May 2018.